TOP RANKED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and IRNT Pharmaceutical Investing
AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Veklury® is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19 Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, AI and ABBV Pharmaceutical Investing
ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
LAWSUITS FILED AGAINST MP, CRNC and AUPH - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS Pharmaceutical Investing
SHAREHOLDER ALERT: AI GRAB ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere myPath Digital Health App Pharmaceutical Investing
KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th Pharmaceutical Investing
Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance Pharmaceutical Investing
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
